Current medulloblastoma subgroup specific clinical trials

Medulloblastoma is a heterogeneous disease with at least four distinct molecular subgroups: wingless (WNT), sonic hedgehog (SHH), Group 3, and Group 4. Recently there has been considerable progress defining the molecular drivers and prognostic factors of each subgroup. However, this information has...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Eric M., Ashley, David, Landi, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237968/
https://www.ncbi.nlm.nih.gov/pubmed/32477916
http://dx.doi.org/10.21037/tp.2020.03.03

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237968/
https://www.ncbi.nlm.nih.gov/pubmed/32477916
http://dx.doi.org/10.21037/tp.2020.03.03

Ejemplares similares